Material Event Form 8 K

ITEM 8.01 - OTHER EVENTS

CS Diagnostics Corp, a renowned member of the CS Group and medical distribution company dedicated to improving patient care through innovative solutions. By working closely with trusted global healthcare partners, experienced professionals and top universities CS Diagnostics Corp. is focused on prevention, improving therapy results by being safer and causing less side effects. One of such products is the CS Protect Hydrogel. This novel spacer gel has been specially developed to separate healthy from malignant tissues during Radiation therapy, thereby significantly improving the chances of recovery for prostate cancer patients, for example. Increasing the effectiveness and safety of the therapy is giving patients much more comfort and Quality of life.

Future products are only included in the CS Diagnostics Corp. portfolio after being intensively tested to the highest standards.

CS Diagnostics Corp. serves a diverse international market and is well experienced in carrying out complicated regulatory procedures to achieve product approvals and Marketing authorizations. Its global presence strengthens strategic collaborations with healthcare providers around the world, ensuring that its comprehensive services and solutions are available in multiple countries. With a focus on quality and a broad range of solutions, CS Diagnostics Corp. is well positioned to transform the future of healthcare by delivering on the promise of better health and vitality through better technology.

Company Officers & Contacts

Thomas Fahrhoefer, President

Thomas Josef Migotsch, Vice President, COO

Mohammad EsSayed, Vice President, CFO

Janel Luzana, Company Secretary

Mahmoud A. Al-Sayyed, Independent Director

Lauren Kate Ugur, Independent Director

Public link

Please use the above public link if you want to share this noodl on another website.